Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND Plasminogen activator inhibitor-1 (PAI-1) is increased in kidneys of humans and animals with diabetic nephropathy and is associated with extracellular matrix (ECM) accumulation. PAI-1 may promote ECM buildup by preventing plasmin and matrix metalloproteinase (MMP) activation. However, the importance and mechanism of PAI-1 action in the pathogenesis of diabetic nephropathy is unknown. METHODS We investigated the effect of streptozotocin (STZ)-induced diabetes in wild-type (PAI-1(+/+)) mice and mice null for PAI-1 (PAI-1(-/-)). After 1 month of diabetes, animals were placed in metabolic cages for 24-hour urine collection. Total RNA was isolated from kidney cortex for reverse transcription-polymerase chain reaction (RT-PCR) and Northern blot analysis, and Western blots were quantitated from cortical protein. Primary mesangial cells were grown from Sprague-Dawley rats and used in signal transduction studies. RESULTS Urinary albumin excretion (UAE) in diabetic PAI-1(+/+) mice increased >threefold, but remained unchanged in PAI-1(-/-) mice. Transforming growth factor-beta (TGF-beta) and fibronectin message and protein levels were lower in diabetic PAI-1(-/-) vs. PAI-1(+/+) mice, suggesting that PAI-1 deficiency impaired TGF-beta expression despite diabetes. Indeed, recombinant PAI-1 directly stimulated TGF-beta message and protein via mitogen-activated protein kinase (MAPK) signal transduction in cultured mesangial cells. Urokinase plasminogen activator (uPA) inhibited this PAI-1 action in a dose-dependent manner. The inhibitory effect of antibody to uPA receptor (uPAR) on PAI-1-induced TGF-beta function suggested that uPAR mediated the cellular effect of PAI-1. CONCLUSION PAI-1 can regulate TGF-beta expression by binding to uPAR and activating the extracellular-regulated signal kinase (ERK)/MAPK pathway. Therefore, PAI-1 contributes to diabetic nephropathy by regulating TGF-beta and renal ECM production and may be a therapeutic target in diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Varga, J., Rosenbloom, J., & Jimenez, S. A. (1987) · Biochemical Journal · doi:10.1042/bj2470597 · Cited by 591
Chen, Y.-Q., Su, M., Walia, R. R., Hao, Q., Covington, J. W., & Vaughan, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8225 · Cited by 217 · cited 1×
“The increase in tissue PAI-1 likely occurs in response to factors inherent to the diabetic environment such as increased transforming growth factor-β (TGF-β), hyperglycemia, very low-density lipoprotein (VLDL) triglycerides, and angiotensin II (Ang II), all of which activate the PAI-1 promote”
Background
Cited by
Targeting the progression of chronic kidney disease
Ruiz-Ortega, M., Rayego-Mateos, S., Lamas, S., Ortiz, A., & Rodrigues-Diez, R. R. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0248-y · Cited by 979
Wnt/β-catenin signaling and kidney fibrosis
Tan, R. J., Zhou, D., Zhou, L., & Liu, Y. (2014) · Kidney International Supplements · doi:10.1038/kisup.2014.16 · Cited by 278
Palella, E., Cimino, R., Pullano, S. A., Fiorillo, A. S., Gulletta, E., Brunetti, A., Foti, D. P., & Greco, M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17010300 · Cited by 48
Pathogenesis of diabetic complications: Exploring hypoxic niche formation and HIF-1α activation
Bi, J., Zhou, W., & Tang, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116202 · Cited by 19
Metadata
- Authors
- Nicholas, S. B., Aguiniga, E., Ren, Y., Kim, J., Wong, J., Govindarajan, N., Noda, M., Wang, W., Kawano, Y., Collins, A., & Hsueh, W. A.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 67
- Issue
- 4
- Pages
- 1297-1307
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2012194625
- Cited by
- 153
- References
- 2
- FWCI
- 8.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy. https://app.cochat.ai/papers/10.1111/j.1523-1755.2005.00207.x
- The paper
- Nicholas, S. B., Aguiniga, E., Ren, Y., Kim, J., Wong, J., Govindarajan, N., Noda, M., Wang, W., Kawano, Y., Collins, A., & Hsueh, W. A. (2005). Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy. Kidney International. https://doi.org/10.1111/j.1523-1755.2005.00207.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.